Literature DB >> 24676934

Bilateral pseudoangiomatous stromal hyperplasia tumors in axillary male gynecomastia: report of a case.

Roger M Vega1, David Pechman, Burco Ergonul, Carmen Gomez, Mecker G Moller.   

Abstract

Pseudoangiomatous stromal hyperplasia (PASH) is a rare benign proliferation of breast stromal cells with a complex pattern of interanastomosing spaces lined by myofibroblasts. The exact etiology is still unknown, but a proliferative response of myofibroblasts to hormonal stimuli has been postulated. PASH is a relatively common incidental finding in breast tissue removed for other reasons and rarely manifests as a localized mass. Fewer than 150 cases of tumoral PASH have been reported since it was first described in 1986. Although PASH tends to grow over time, most lesions are cured by surgical excision and the prognosis is excellent. We report an unusual case of bilateral axillary tumoral PASH in a 44-year-old man. Awareness of this disease is important when considering the differential diagnosis of axillary masses. To our knowledge, only one other case of unilateral axillary tumoral PASH in a male patient has been described in English and this is the first case of PASH occurring in male bilateral axillary gynecomastia.

Entities:  

Mesh:

Year:  2014        PMID: 24676934     DOI: 10.1007/s00595-014-0892-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  Supernumerary nipples and accessory breast tissue.

Authors:  H T Gilmore; M Milroy; B J Mello
Journal:  S D J Med       Date:  1996-05

2.  Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum.

Authors:  R E Ibrahim; C G Sciotto; N Weidner
Journal:  Cancer       Date:  1989-03-15       Impact factor: 6.860

3.  Nodular pseudoangiomatous stromal hyperplasia of the breast. Cytologic features.

Authors:  B Vicandi; J A Jiménez-Heffernan; P López-Ferrer; L Ortega; J M Viguer
Journal:  Acta Cytol       Date:  1998 Mar-Apr       Impact factor: 2.319

4.  Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a clinicopathological study of 79 cases.

Authors:  Eva K Drinka; Archana Bargaje; Çağatay H Erşahin; Priya Patel; Alia Salhadar; James Sinacore; Prabha Rajan
Journal:  Int J Surg Pathol       Date:  2011-08-23       Impact factor: 1.271

5.  Pseudoangiomatous stromal hyperplasia (PASH). A mammary stromal tumor with myofibroblastic differentiation.

Authors:  C M Powell; M L Cranor; P P Rosen
Journal:  Am J Surg Pathol       Date:  1995-03       Impact factor: 6.394

6.  Pseudoangiomatous stromal hyperplasia. A case for bilateral mastectomy in a 12-year-old girl.

Authors:  Kimberly A Singh; Melinda M Lewis; Robyn L Runge; Grant W Carlson
Journal:  Breast J       Date:  2007 Nov-Dec       Impact factor: 2.431

7.  Pseudoangiomatous hyperplasia of male breast.

Authors:  S Badve; J P Sloane
Journal:  Histopathology       Date:  1995-05       Impact factor: 5.087

8.  Immunocytochemical analysis of estrogen and progesterone receptors in benign stromal lesions of the breast. Evidence for hormonal etiology in pseudoangiomatous hyperplasia of mammary stroma.

Authors:  C Anderson; A Ricci; C A Pedersen; R W Cartun
Journal:  Am J Surg Pathol       Date:  1991-02       Impact factor: 6.394

9.  Pseudoangiomatous stromal hyperplasia: mammographic and sonographic appearances.

Authors:  M R Polger; C M Denison; S Lester; J E Meyer
Journal:  AJR Am J Roentgenol       Date:  1996-02       Impact factor: 3.959

10.  Pseudoangiomatous stromal hyperplasia (PASH) of the breast: a series of 24 patients.

Authors:  Erin Bowman; Gabriela Oprea; Joel Okoli; Kathleen Gundry; Monica Rizzo; Sheryl Gabram-Mendola; Upender Manne; Geoffrey Smith; Stefan Pambuccian; Harvey L Bumpers
Journal:  Breast J       Date:  2012 May-Jun       Impact factor: 2.431

View more
  1 in total

1.  Pseudoangiomatous stromal hyperplasia in a healthy young adult male.

Authors:  Shahin C Owji; Neel Shroff; Angelica S Robinson; Flavia E Posleman Monetto
Journal:  Radiol Case Rep       Date:  2022-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.